Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-02 Sale | 2026-01-05 7:52 pm | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 1,644 | $6.88 | $11,311 | 10,189 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:51 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 2,586 | $6.88 | $17,792 | 42,796 (Indirect Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:50 pm | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 297 | $6.88 | $2,043 | 12,857 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:50 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 876 | $6.88 | $6,027 | 20,681 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 7:49 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 876 | $6.88 | $6,027 | 13,978 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:35 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 8,526 | $0.2935 | $2,502 | 205,568 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:34 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 25,123 | $0.2935 | $7,374 | 453,824 (Indirect Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:33 pm | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 10,842 | $0.2935 | $3,182 | 118,332 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:33 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 8,526 | $0.2935 | $2,502 | 148,542 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:32 pm | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 2,897 | $0.2935 | $850 | 121,545 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:05 pm | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 10,826 | $0.5619 | $6,083 | 129,174 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:04 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 25,107 | $0.5619 | $14,108 | 478,947 (Indirect Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:03 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 8,510 | $0.5619 | $4,782 | 204,094 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:01 pm | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 2,881 | $0.5619 | $1,619 | 114,442 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:00 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 8,510 | $0.5619 | $4,782 | 157,068 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-31 Exercise | 2026-01-05 7:52 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 4,667 | $0 | 10,189 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 10,834 | $0 | 42,796 (Direct) | View |
| 2025-11-18 Option Award | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 1,000 | $2.31 | 12,857 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 1,236 | $0 | 12,857 (Direct) | View |
| 2025-11-18 Option Award | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 1,000 | $2.31 | 20,681 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 3,667 | $0 | 20,681 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 7:49 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 3,667 | $0 | 13,978 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:19 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | Renninger Robert Chief Financial Officer | 34,358 | $0 | 34,358 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:17 pm | N/A 2035-09-24 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 133,526 | $0 | 133,526 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:15 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 35,138 | $0 | 35,138 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:14 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 44,508 | $0 | 44,508 (Direct) | View |
| 2025-12-24 Option Award | 2025-12-29 4:12 pm | N/A 2035-09-23 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 34,358 | $0 | 34,358 (Direct) | View |
| 2025-12-23 Option Award | 2025-12-23 5:12 pm | N/A N/A | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Perceptive Xontogeny Venture Fund II LP Director 10% Owner | 5,502,402 | $0 | 17,505,255 (Indirect) | View |
| 2025-12-23 Option Award | 2025-12-23 5:12 pm | N/A N/A | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Perceptive Xontogeny Venture Fund II LP Director 10% Owner | 11,161,543 | $6.35 | 17,505,255 (Indirect) | View |
| 2025-12-23 Option Award | 2025-12-23 5:12 pm | 2025-12-23 N/A | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Perceptive Xontogeny Venture Fund II LP Director 10% Owner | 1,830,580 | $6.349 | 17,505,255 (Indirect) | View |
| 2025-05-19 Option Award | 2025-07-02 4:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 10,000 | $0.2312 | 205,568 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 36,666 | $0 | 205,568 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:34 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 108,334 | $0 | 453,824 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:33 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 46,666 | $0 | 118,332 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:33 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 36,666 | $0 | 148,542 (Direct) | View |
| 2025-05-19 Option Award | 2025-07-02 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 10,000 | $0.2312 | 121,545 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 12,359 | $0 | 121,545 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:37 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:36 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | Panzara Michael A. Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:35 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | Romano Kelly A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:34 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:34 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:33 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 5:32 pm | N/A 2035-05-29 | Athira Pharma Inc. | ATHA | PICKERING GRANT Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2025-03-03 Option Award(A) | 2025-03-12 5:20 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 73,350 | $0 | 73,350 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:31 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Renninger Robert SVP, Finance and Accounting | 170,850 | $0 | 170,850 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:30 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 146,408 | $0 | 146,408 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:29 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 556,358 | $0 | 556,358 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:29 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 185,450 | $0 | 185,450 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-04 4:28 pm | N/A 2035-03-02 | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 143,158 | $0 | 143,158 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:05 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 46,667 | $0 | 129,174 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:04 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 108,333 | $0 | 478,947 (Direct) | View |
| 2024-11-18 Option Award | 2025-01-03 5:03 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 9,920 | $0.55 | 204,094 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:03 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 36,667 | $0 | 204,094 (Direct) | View |
| 2024-11-18 Option Award | 2025-01-03 5:01 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 3,651 | $0.55 | 114,442 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:01 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 12,359 | $0 | 114,442 (Direct) | View |
| 2024-11-18 Option Award | 2025-01-03 5:00 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 3,651 | $0.55 | 157,068 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 5:00 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 36,667 | $0 | 157,068 (Direct) | View |
| 2024-10-03 Option Award(A) | 2024-10-03 9:50 pm | N/A 2034-10-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:17 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 74,154 | $0 | 74,154 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:13 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:10 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:08 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-03 7:07 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 650,000 | $0 | 650,000 (Direct) | View |